January 29, 2025
Ascentage Pharma Announces Closing of U.S. Initial Public Offering
ROCKVILLE, Md. and SUZHOU, China, Jan. 28, 2025 (GLOBE NEWSWIRE) — Ascentage Pharma (Nasdaq: AAPG) (HKEX: 6855) announced today the…
Pharmaceuticals, Biotechnology and Life Sciences
ROCKVILLE, Md. and SUZHOU, China, Jan. 28, 2025 (GLOBE NEWSWIRE) — Ascentage Pharma (Nasdaq: AAPG) (HKEX: 6855) announced today the…
Reported a robust objective response rate of 75.5% from the Phase 1 study of NX-5948 in patients with relapsed/refractory CLL/SLL…
NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a…
The grant funding will further Tevogen Bio’s mission to develop therapies for treatment of cancers and viral infections.Tevogen Bio may…
DALLAS, Jan. 28, 2025 (GLOBE NEWSWIRE) — Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven…
The Base Shelf Prospectus is accessible, and the Prospectus Supplement will be accessible within two business days, through SEDAR+ NOT…
European Patent Office (EPO) grants EU Patent No. EP3583125 B1 covering the Company’s Fully Human Albumin Binding (FHAB®) domain fusion…
– 400 participants with a medium-to-high risk of developing colorectal cancer (CRC) have been enrolled across two arms – –…
NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical…
Novadip Biosciences, a clinical stage biotechnology company specializing in regenerative medicine, Tuesday said it has completed the 12-month post-surgical visit…